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ABSTRACT
Objective To determine the prevalence of depression and
anxietyinterminallyillpatientspursuingaidindyingfrom
physicians.
Design Cross sectional survey.
Setting State of Oregon, USA.
Participants 58 Oregonians, most terminally ill with
cancer or amyotrophic lateral sclerosis, who had either
requested aid in dying from a physician or contacted an
aid in dying advocacy organisation.
Main outcome measures Diagnosis of depression or
anxiety according to the hospital anxiety and depression
scale and the structured clinical interview for the
Diagnostic and Statistical Manual of Mental Disorders.
Results 15 study participants met “caseness” criteria for
depression,and13metcriteriaforanxiety.42patientsdied
bytheendofthestudy;18receivedaprescriptionforalethal
drugundertheDeathwithDignityAct,andninediedbylethal
ingestion. 15 participants who received a prescription for a
lethaldrugdidnotmeetcriteriafordepression;threedid.All
three depressed participants died by legal ingestion within
two months of the research interview.
Conclusion Although most terminally ill Oregonians who
receiveaidin dyingdonothavedepressivedisorders,the
current practice of the Death with Dignity Act may fail to
protect some patients whose choices are influenced by
depression from receiving a prescription for a lethal drug.
INTRODUCTION
In 1994 the voters of Oregon passed the Death with
DignityAct,whichlegalisedthepracticeofphysicians’
aid in dying for terminally ill patients. This law
authorises a physician to prescribe a lethal dosage of
drug,usuallyashortactingbarbiturate,toacompetent,
requesting patient for the purposes of self
administration.
1 Several safeguards in the law ensure
that patients are adult, competent, terminally ill, and
choosing to end life voluntarily but not impulsively
(box).Sinceenactmentofthelawin1997,betweenone
and two out of every thousand deaths in Oregon has
been by lethal ingestion.
1
Theextenttowhichpotentiallytreatablepsychiatric
disorders may influence patients’ decisions for aid in
dying has been debated. For people at the end of life,
depression,hopelessness,andpsychosocialdistressare
among the strongest correlates of desire for hastened
death.
2-9 Eighty per cent of patients with cancer who
complete suicide have a mood disorder, and, in
primary care populations, treatment of depression
reduces suicidal ideation.
10-14 The Death with Dignity
Act requires that if the prescribing or consulting
physician is concerned that the patient’s judgment is
impairedby amentaldisorder(suchasdepression)the
patient must be referred to a psychiatrist or a
psychologist. No drug can be prescribed until the
mental health professional determines that the patient
does not have a mental disorder causing impaired
judgment.
1 Physicians, hospice professionals, and
family members of patients in Oregon who pursue
aid in dying generally do not believe that depression
influenceschoicesforhasteneddeath.
15-17In2007none
of the people who died by lethal ingestion in Oregon
hadbeenevaluatedbyapsychiatristorapsychologist.
1
Healthcare professionals, however, often fail to recog-
nise depression, particularly among medically ill
patients.
18-20 The goal of this study was to determine
the prevalence and severity of psychological distress,
including major depressive disorder, in Oregonians
who request aid in dying.
METHODS
We used several sources to notify patients of the
opportunitytoparticipateinourstudy.Somepotential
participantshadcontactedCompassionandChoicesof
Oregon for information about accessing aid in dying.
Compassion and Choices is an organisationthat offers
informationandassistancetopeoplewhochooseaidin
dying in Oregon. In 2006 Compassion and Choices
gave information to or attended the deaths of three
quarters of patients who chose aid in dying.
21 Other
potential participants made an explicit request for aid
in dying to a physician as outlined in the Death with
DignityAct.Ethicsconsultantsandpalliativemedicine
and oncology specialists in northwest Oregon invited
these patients to participate. Patients referred from all
sources contacted study personnel directly for more
information about enrolling. All patients gave written
informed consent to participate.
The study psychologist (ERG) administered all
measures in the participant’s home. We used the
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participants’ capacity to consent to research.
22 Once
enrolled, participants confirmed that they had
expressed interest in obtaining aid in dying through
Compassion and Choices or explicitly requested aid in
dying from a physician. The protocol required exclu-
sionofparticipantswithcognitiveimpairment(23orless
ontheFolsteinMcHughmini-mentalstateexamination
or 7 or less on the short portable mental status
questionnaire
23-25). The psychologist administered the
hospital anxiety and depression scale,
26 which includes
seven depression items and seven anxiety items, each
ratedona0-3scale.Forthepurposesofidentifyingcases
and consistent with expert recommendations, we
identifiedparticipantswithhospitalanxietyanddepres-
sion scale depression scores of 11 or greater as
“depressed” and those with anxiety scores of 10 or
greater as “anxious.”
27 The psychologist administered
the 20 item Beck hopelessness scale,
28 a well validated
measureofhopelessness,whichisapredictorofsuicidal
ideation and suicide attempts.
2930 We designated those
with scores of 10 or greater as “hopeless.”
The psychologist completed the current mood
disorder section of the structured clinical interview
for American Psychiatric Association Diagnostic and
Statistical Manual-IV axis I disorders (SCID-I), a
standard research instrument for diagnosing mental
disorders.
31 Because knowing that the patient has
requested aid in dying may influence diagnostic
thresholds for depression, the SCID interview was
audiotaped and the tapes were reviewed by a research
psychiatrist(SKD)whodidnot knowif the patienthad
requested aid in dying (19 audiotapes from terminally
ill patients who had not requested aid in dying were
randomly interspersed). Based on studies by Chochi-
nov and colleagues,
32 the severity of depressed mood
oranhedonianeededtobeatleastmoderateforthetwo
weeks before the interview in order to reach the
threshold for diagnosis. Chochinov et al also reported
that when moderate thresholds were used for mood
criteria, presence or absence of physical symptoms
(such as weight loss or fatigue) no longer influenced
categorisation of depression. Using an inclusive
approach, we attributed all physical symptoms of
depression to the diagnosis of depression, even if they
mightbearesultofterminaldisease.Thoughtsofdeath
orsuicideandsuicidalplansorattemptsarecriteriafor
majordepressivedisorderinthe AmericanPsychiatric
Association Diagnostic and Statistical Manual.
31 We
attributedsuicidalideationtoadiagnosisofdepression
only if the patient endorsed suicidal thoughts or plans
aside from aid in dying. The final SCID diagnosis of
majordepressivedisorderwasreachedbyconsensusif
ERG and SKD disagreed. For the purposes of
identifying cases of depression, we considered partici-
pantstobedepressediftheirSCIDwaspositiveortheir
hospitalanxietyand depressionscaledepressionscore
was 11 or greater.
27
Participants rated their overall suffering in the two
weeks before the interview on an 11 point scale with
end points labelled 0=“I have not suffered” and 10=“I
have suffered severely.”
33 They rated their quality of
lifeintheprevioustwoweeksonan11pointscalewith
0=“Q u a l i t yo fl i f ea sg o o da si tc a nb e ” and
10=“Terrible, very bad quality of life.” Participants
rated their desire for death in the two weeks preceding
the interview on an 11 point scale with end points
labelled 0=“I desire to live as long as possible” and
10=“I have a strong desire to die soon.” Participants
rated the influence of depression as a reason for
requestingaidindyingona scaleonwhich1=“depres-
sion not at all important in the decision to request a
lethalprescription”and5=“depressionvery important
in the decision to request a lethal prescription.”
All participants diagnosed with major depressive
disorder were notified of this result at the time of the
study visit, and the study psychologist recommended
treatment and offered to facilitate counselling. As is
standardatourinstitution,asafetyplanwasdeveloped
sothatallpatientswhoseemedupsetbyparticipationin
the study or were found to be imminently suicidal by
means other than legalised assisted dying would be
referredforanevaluationofmentalhealth.Otherwise,
participants were assured confidentiality in order to
facilitate honest disclosure. We obtained information
onoutcomes—whetherthestudyparticipantreceiveda
prescription of a lethal drug or died by lethal ingestion
—sixmonthsormoreafterallotherdatacollectionwas
complete.
Data analysis
We present data as frequencies and proportions for
categoricalitemsandasmeansandstandarddeviations
for normally distributed continuous items. We used
Student’s t test to compare means. All tests were two
tailed and α was set at 0.05.
LegalrequirementsoftheOregonDeathwithDignityAct
1
The attending physician who is responsible for care of the patient’s terminal illness must
ensure that:
 The patient is aged 18 years or above
 The patient is a resident of the state of Oregon
 The patient has made one written and two oral requests separated by 15 days
 Thepatientunderstandstherisksofaidindyingandthealternatives,includinghospice
and comfort care
 The patient is assessed by a consulting physician
 Information about the patient is reported to the Oregon Department of Human Services
The attending and consulting physicians must ensure that:
 The patient is capable of making and communicating healthcare decisions
 The decision is voluntary
 The patient has a terminal illness that would, within reasonable medical judgment,
cause death within six months
 The patient is referred to a psychologist or psychiatrist if concern exists that the patient
has a psychiatric disorder including depression that may impair judgment
Information from statistical reports are compiled by the Oregon Department of Human
Services and published yearly
1
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Of 178 Compassion and Choices clients notified of the
opportunity to participate in the study, 12 were
ineligible or deceased and 47 (28%) enrolled. The
other 11 participants were referred from clinicians at
other medical centres. No patients were excluded
because of cognitive impairment or lack of capacity to
consent to research. The mean age of the 58 patients
requestingaidindyingwas66(SD12)years.Thirtyone
participantswerewomen,22weremarried,and21were
enrolled in a hospice at the time of the interview. The
mostcommonterminaldiseaseswerecancer(n=44)and
amyotrophic lateral sclerosis (n=7). At the time of the
study interview 46 patients had explicitly requested aid
in dying from a physician and 47 had contacted
Compassion and Choices to obtain aid in dying.
Eightparticipantsscored11orhigheronthehospital
anxiety and depression scale for depression, 13 scored
10orgreaterontheanxietysubscale,and11scored10
or higher on the Beck hopelessness scale. Twelve
participants were diagnosed with depression by the
SCID. Fifteen participants met our criteria for depres-
sion by being depressed on the SCID or having a
hospitalanxietyand depressionscaledepressionscore
of 11 or higher. The mean desire to die among
depressed participants was 5.7 (SD 3.0) on our 11
point scale. Seven of the depressed group did not
attributetheirpursuitofaidindyingtodepressionatall
(score=1), but six felt that depression somewhat or
stronglyinfluencedtheirpreferenceforhasteneddeath
(scores=3,4,or5).Anoffertofacilitatecounsellingwas
madetoalldepressedpatients,butonlyoneparticipant
(patient C below) agreed.
Amongthe42participantswhodiedbytheendofthe
study, 18 received a prescription for a lethal drug and
nine died by lethal ingestion. Among decedents, no
significant differences existed between those who
received a prescription for a lethal drug and those
who did not on measures of psychosocial distress,
except that those who received a prescription had
(surprisingly) a lower desire to die and a trend toward
lower hopelessness scores (table 1).
Three of the 18 participants who received a prescrip-
tion for a lethal drug met our criteria for depression on
eithertheSCIDorhospitalanxietyanddepressionscale
(table 2),and15didnot.Allthreediedbylethalingestion
in their home within two months of the interview. None
h a db e e ne v a l u a t e db yam e n t a lh e a l t hp r o f e s s i o n a l
beforeparticipationintheresearch.PatientA,anelderly
man with cancer who was receiving home hospice
services, met “caseness” criteria on the hospital anxiety
and depression scale with a depression score of 12,
although his SCID result was negative. Patient B, a
middle aged woman with cancer who was receiving
home hospice services, was depressed by SCID criteria.
Shedeclinedtocompletethehopelessnessscalebecause
she had “trouble with the entire concept of hope.” She
rated her desire to die and her suffering as quite high.
Whether patients A and B received mental health
evaluation or treatment after participation in the study
is unknown. Patient C, an elderly woman with cancer,
was depressed by SCID criteria. She received treatment
for depression with a psychostimulant after completion
of the survey, was subsequently enrolled in a hospice,
and was documented by a psychiatrist to have a
remission in her depression before her death. She
received the prescription when she was depressed, and
she reported that depression somewhat influenced her
decision to pursue aid in dying.
DISCUSSION
Among patients who requested a physician’s aid in
dying, one in four had clinical depression. However,
more than three quarters of people who actually
received prescriptions for lethal drugs did not have a
depressivedisorder.Ourfindingsalsoindicatethatthe
current practice of legalised aid in dying may allow
some potentially ineligible patients to receive a
prescription for a lethal drug; two of those who
ultimately died by lethal ingestion had depression at
the time they received a prescription for a lethal drug
and died by ingesting the drug. A third patient was
depressed at the time that she requested a physician’s
aid in dying and probably received her prescription;
she was successfully treated for her depression before
she died by lethal ingestion.
Strengths and limitations
Althoughmanyinvestigatorshaveexaminedthedegree
to which depression is associated with a desire to die
among terminally ill patients,
2-9 we believe that our
studyisthefirsttousestandardisedmeasurestoexamine
theprevalenceandseverityofdepressionandanxietyin
agroupofpatientswhohaveactuallyrequestedandare
potentially eligible to receive aid in dying.
The strengths of our study include a standard
measure of depression (SCID) and a blinding system
thatcontrolledfortheeffectontheultimatepsychiatric
diagnosis of the psychiatrist knowing that the patient
had requested a physician’s aid in dying. The other
measures of depression and anxiety are commonly
Table 1 |Comparison of deceased participants who received and did not receive
prescription for lethal drug. Values are mean (SD) unless stated otherwise
Measure
Received
prescription
(n=18)
Did not receive
prescription
(n=22)
P value (t
test
Hospital anxiety and depression scale—anxiety* 4.8 (3.2) 7.0 (5.1) 0.12
Hospitalanxietyanddepressionscale—depression† 5.7 (3.4) 7.3 (4.4) 0.19
Hospital anxiety and depression scale—total‡ 10.5 (5.4) 14.3 (8.6) 0.10
Beck hopelessness scale§ 5.0 (3.0) 7.5 (5.4) 0.08
Desire to die¶ 1.5 (2.6) 4.7 (3.7) 0.004
Suffering** 3.7 (2.7) 4.5 (2.9) 0.36
Quality of life†† 4.0 (1.8) 5.1 (2.9) 0.13
*Scores range from 0 (no anxiety) to 21 (severe anxiety).
26
†Scores range from 0 (no depression) to 21 (severe depression).
26
‡Sum of anxiety and depression scales.
26
§Scores range from 0 (not hopeless) to 20 (very hopeless).
28
¶11 point scale: 0=Id e s i r et ol i v ea sl o n ga sp o s s i b l e ;1 0 =I have a strong desire to die soon.
**11 point scale: 0=I have not suffered in the past two weeks; 10=I have suffered severely in the past two
weeks.
33
††11 point scale: 0=quality of life in past two weeks is as good as it can be; 10=quality of life in past two weeks
is terrible, very bad.
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study has several limitations. Use of an inclusive
approach to categorise somatic symptoms, which, if
present, were attributed to depression and not to
terminal disease, carries the risk of inflating the
prevalence of depressive disorder. In addition, only
28% of invited patients who requested aid in dying
agreed to participate; uncertainty exists about the
degreetowhichourdataaregeneralisabletotheentire
population of patients who request physicians’ aid in
dying. In a study of Oregon physicians who reported
on 141 requests for aid in dying, only 36% of patients
were in a hospice at the time of the request—similarly,
only a third of our participants were yet enrolled in a
hospice.
34 In contrast, data collected by the Oregon
Department of Human Services indicates that 86% of
patients who die by prescription of a lethal drug are
enrolled in a hospice before death.
1 This suggests that
mostpatientsbegininquiringaboutaphysician’saidin
dying before they enrol in a hospice. Our finding of a
low proportion in hospice enrollees reflects this fact,
rather than differences between our sample and all
Oregonians who die by legal lethal ingestion.
The possibility remains that the three depressed
patients who died by lethal ingestion satisfied the
requirements of the Death with Dignity Act if the
attending physician determined that depression was
present but not influencing their judgment. The study
participants themselves were divided in whether to
attribute their interest in aid in dying to low mood.
Although diagnosing depression can be relatively
straightforward, determining its role in influencing
decision making is more difficult, even by expert
assessment.Forexample,inastudyof321psychiatrists
in Oregononly6% were veryconfident thatina single
evaluationtheycouldadequatelydeterminewhethera
psychiatric disorder was impairing the judgment of a
patient requesting assisted suicide.
35 In a study of 290
US forensic psychiatrists, 58% indicated that the
presence of major depressive disorder should result
in an automatic finding of incompetence for the
purposes of obtaining assisted suicide.
36 These data
support that of the two components of the mental
health assessment—presence of a disorder and deter-
mination of its influence—the greatest weight in
determining eligibility for aid in dying should be on
whether a relevant mental disorder such as depression
can be diagnosed.
Depression and desire for death
OtherstudiesandsurveysfromOregonhaveindicated
thataidindyingamongdepressedpatientsisveryrare.
Physicians in Oregon who received requests for aid in
dying from 143 patients after enactment of the Death
withDignityActreportedthat20%weredepressed—a
proportioncomparabletowhatwefoundinthisstudy.
None of the depressed patients on whom they
submitted information received a prescription for a
lethaldrug.
34Studiesofhealthcareproviders,including
hospice professionals, and family members in Oregon
indicate that they believe that depression was rarely a
factor influencing requests for a physician’s aid in
dying.
15-17 Our study suggests that in some cases
depression is missed or overlooked.
In contrast, studies of interest in euthanasia from
populations outside ofOregon suggestthat depression
and psychosocial distress are prominent among
patients who endorse an interest in hastened death.
For example, in a study of 200 terminally ill inpatients
with cancer, the prevalence of depressive syndromes
was 59% among patients with a serious and pervasive
desiretodiebutonly8%amongpatientswithoutsucha
desire.
6Inastudyof988terminallyillpatientslivingin
areas where physicians’ aid in dying was not legal,
10.6% reported seriously considering euthanasia or a
physician’saidindyingforthemselves,andthosewith
depressivesymptomswere25%morelikelytoendorse
this.
9 In a study of 98 patients admitted to a palliative
care inpatient setting in the northeast United States,
patients with major depression were four times more
likely to have a high desire for hastened death.
8
Whether findings from these patient groups can be
extrapolated to patients who have actively requested
legalphysicians’aid indyinghasremaineduncertain—
although 17% of Oregonians are potentially interested
in aid in dying, only 1-2% actually request it.
3437 For
example, in a study of 161 patients with cancer in
Oregon who were longitudinally examined for interest
inaphysician’saidindying,19hadaseriousinterestin
aid in dying, fewer than half with a serious interest
discussed aid in dying with their physician, two
requested a prescription for a lethal drug, and none
received one.
38 This suggests that most terminally ill
patients who declare interest in aid in dying do not
actively pursue aid in dying under legalised conditions.
As such, studies of preferences for aid in dying in these
groups may misrepresent actual requesters of aid in
dying. In contrast, our surveyed participants had taken
activestepstopursueaphysician’saidindyinginoneof
the few jurisdictions where it is legal—all either
Table 2 |Measures of psychological distress in depressed participants who received a
physician’s aid in dying
Measure Case A Case B Case C
SCID depression* – ++
Hospital anxiety and depression scale—anxiety† 74 8
Hospital anxiety and depression scale—depression‡ 12 10 9
Hospital anxiety and depression scale—total§ 19 14 17
Beck hopelessness scale¶ 9N A 9
Desire to die** 6 8 5
Suffering†† 48 5
How much depressed mood influenced decision‡‡ 11 3
NA=not available; SCID=structured clinical interview for American Psychiatric Association Diagnostic and
Statistical Manual-IV
*+ indicates major depressive disorder present; – indicates major depressive disorder absent.
31
†Scores range from 0 (no anxiety) to 21 (severe anxiety).
26
‡Scores range from 0 (no depression) to 21 (severe depression).
26
§Sum of anxiety and depression subscales.
26
¶Scores range from 0 (not hopeless) to 20 (very hopeless).
28 Case B declined to complete this scale.
**11 point scale: 0=I desire to live as long as possible; 10=I have a strong desire to die soon.
††11 point scale: 0=I have not suffered in the past two weeks; 10=I have suffered severely in the past two
weeks.
33
‡‡1=depressed mood not at all important in decision to request prescription; 5=depressed mood very important
in decision to request prescription.
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contacted Compassion and Choicesfor information on
the Oregon Death with Dignity Act. Before death,
almosthalfhadobtainedaprescriptionforalethaldrug
under the law.
Conclusions
Our study suggests that most patients who request aid
in dying do not have a depressive disorder. However,
the current practice of the Death with Dignity Act in
Oregon may not adequately protect all mentally ill
patients, and increased vigilance and systematic
examination for depression among patients who may
access legalised aid in dying are needed. Tools for
screeningfordepressionsuchasthoseusedinourstudy
are easy to administer and may help to determine
which patients need further evaluation by a mental
health professional. Further study is needed to
determine the effect of treatment of depression on the
choice to hasten death.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
The state of Oregon legalised physicians’ aid in dying in 1997
Physicians,hospiceprofessionals,andfamilymembersofpatientswhorequestalethaldrug
do not believe that depression is an important reason why patients pursue aid in dying
WHAT THIS STUDY ADDS
AmongterminallyillOregonianswhoparticipatedinourstudyandreceivedaprescriptionfora
lethal drug, one in six had clinical depression
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